At a glance
ClinicalIndex Comparison RecordN/ACompleted· 3,443 enrolled
Drug / intervention
Updated Plasma Collection Feature +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Prospective, Randomized, Controlled, Multicenter Clinical Trial to Demonstrate the Safety and Effectiveness of the NexSys® PCS Plasma Collection System With the Percent Plasma Nomogram (PPN) Feature
In Brief
A clinical study evaluating Updated Plasma Collection Feature and Current Plasma Collection Approach for Apheresis Related Hypotension. Completed, enrolled 3,443 participants across 3 sites.
Detailed Summary
Prospective, multi-center, randomized, controlled clinical trial to study the safety and effectiveness of a novel plasma collection system software.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsApheresis Related Hypotension
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2020202120222023202420252026
Enrollment StartJan 2020
First PostedMar 2020
Primary CompletionMar 2020
Study CompletionApr 2020
TodayJul 2026
First PostedMar 25, 2020
Enrollment StartJan 6, 2020
Primary CompletionMar 27, 2020
Study CompletionApr 27, 2020
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 6.3 years ago
Interventions
Updated Plasma Collection Featuredevice
Plasma collection using a novel, patented system that supports a more individualized collection approach.
Current Plasma Collection Approachdevice
Plasma collection using the current collection approach.